PDE2A inhibitors (Janssen Pharmaceutica)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePDE2A inhibitors (Janssen Pharmaceutica)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodiesterase 2A inhibitors
TargetsPhosphodiesterase 2A
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJanssen Pharmaceutica NV
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A